Active Ingredient History
Emapalumab, sold under the brand name Gamifant, is an anti-interferon-gamma (IFNγ) antibody medication used for the treatment of hemophagocytic lymphohistiocytosis (HLH), which has no cure. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Lymphohistiocytosis, Hemophagocytic (approved 2018)
Allografts (Phase 2)
Arthritis, Juvenile (Phase 3)
Autoimmune Diseases (Phase 2)
Granulomatous Disease, Chronic (Phase 1/Phase 2)
Healthy Volunteers (Phase 1)
Immune System Diseases (Phase 2)
Lupus Erythematosus, Systemic (Phase 3)
Lymphohistiocytosis, Hemophagocytic (Phase 4)
Macrophage Activation Syndrome (Phase 3)
Rare Diseases (Phase 1)
Recurrence (Phase 3)
SARS-CoV-2 (Phase 2/Phase 3)
Still's Disease, Adult-Onset (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue